Kiadis Pharma NV (FRA:K3P) Change In Payables And Accrued Expense : €0.00 Mil (TTM As of Dec. 2020)

View and export this data going back to 2015. Start your Free Trial

What is Kiadis Pharma NV Change In Payables And Accrued Expense?

Kiadis Pharma NV's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2020 was €0.00 Mil. It means Kiadis Pharma NV's Accounts Payable & Accrued Expense stayed the same from Jun. 2020 to Dec. 2020 .

Kiadis Pharma NV's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2020 was €0.00 Mil. It means Kiadis Pharma NV's Accounts Payable & Accrued Expense stayed the same from Dec. 2019 to Dec. 2020 .

Kiadis Pharma NV Change In Payables And Accrued Expense Historical Data

The historical data trend for Kiadis Pharma NV's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV Change In Payables And Accrued Expense Chart

Kiadis Pharma NV Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Kiadis Pharma NV Semi-Annual Data
	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20
Change In Payables And Accrued Expense	Get a 7-Day Free Trial											-	-	-	-	-

Kiadis Pharma NV Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2020 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Kiadis Pharma NV Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Kiadis Pharma NV (FRA:K3P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (FRA:K3P) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP

Website

https://www.kiadis.com

Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (FRA:K3P) Headlines

No Headlines